Search results for: 'inline rail d'

This research service provides revenue forecasts for CROs globally, by phase and market type, R&D spending trends of pharmaceutical and biotechnology companies and pipeline drugs and clinical trial trends by phase and region. For the purpose of this research service, the U.S. CRO markets include revenues derived from the preclinical and clinical...

08 Apr 2021  |  North America  |  Market Research

Strategic Insights into the Global SUV Market

SUVs are no Longer Considered Utilitarian Vehicles; they have Become a Prominent Part of Urban Mobility. Future SUVs Will be Designed to be a Part of Connected Car Networks and Will also Form the Basis of New Urban Mobility

Infographics

×

The SUV is no longer just a utilitarian off-roader whose sole purpose is to transport goods and other essentials over hostile terrain. Over time, these vehicles have evolved and have started playing other roles as well, primarily as people carriers in urban and suburban areas; they are also used to make a statement of social standing in some region...

08 Mar 2022  |  North America  |  Market Outlook

Global Pharmaceuticals Outlook, 2022

The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders

Infographics

×

Key Issues Addressed

Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...

04 Sep 2018  |  North America  |  Market Research

Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018

Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities

Infographics

×

Key Issues Addressed

The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally en...

As the hype continues around Big Data, its ambiguous nature continues to obscure the potential applications of the technology. Clarity is beginning to emerge within the A&D community about how Big Data can be leveraged for 'intelligence amplification' and companies are beginning to respond. This research aims to define these emerging applications a...

Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives for the global drug discovery and early development outsourcing market in this study, which covers research and development (R&D) efforts, market trends, key participants, drivers and restraints of market adoption, and recent mergers and acquisitions. The report ...

CT will evolve as the most important technology for inspecting complex internal geometries and 3-D printed components. CT metrology systems are in a unique position to provide 3-D CT measurement without component configuration. CT scanning can access areas of components normally inaccessible by other metrology techniques. Whether in assembled or pr...

The Healthcare industry has witnessed some of the largest mega-mergers in 2018 – mergers on the provider as well as the payer ends. While this has the potential to bring a shift in power centers in the ecosystem, each stakeholder has relied heavily on inorganic growth to maintain their stronghold. This Mergers and Acquisitions in Life Sciences Indu...

he global life science industry is in a state of flux. While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a crossroad with challenges in scaling-up and commercializing such technologies. In addition, companies...